Racemic Ketamine as an Alternative to Electroconvulsive Therapy for Unipolar Depression: : A Randomized, Open-Label, Non-Inferiority Trial (KetECT)
BackgroundKetamine has emerged as a fast-acting and powerful antidepressant, but no head to head trial has been performed, Here, ketamine is compared with electroconvulsive therapy (ECT), the most effective therapy for depression.MethodsHospitalized patients with unipolar depression were randomized (1:1) to thrice-weekly racemic ketamine (0.5 mg/kg) infusions or ECT in a parallel, open-label, non-
